REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 122 filers reported holding REVANCE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,536,000 | -1.4% | 233,841 | 0.0% | 0.51% | +18.7% |
| Q4 2020 | $6,627,000 | +12.7% | 233,841 | 0.0% | 0.43% | -16.1% |
| Q3 2020 | $5,879,000 | -45.8% | 233,841 | -47.3% | 0.52% | -50.4% |
| Q2 2020 | $10,839,000 | +56.0% | 443,841 | -5.4% | 1.04% | +54.2% |
| Q1 2020 | $6,946,000 | -9.4% | 469,332 | -0.7% | 0.68% | +5.8% |
| Q4 2019 | $7,669,000 | +24.8% | 472,532 | 0.0% | 0.64% | -6.3% |
| Q3 2019 | $6,143,000 | +0.2% | 472,532 | 0.0% | 0.68% | +68.1% |
| Q2 2019 | $6,129,000 | -17.7% | 472,532 | 0.0% | 0.40% | -14.4% |
| Q1 2019 | $7,447,000 | -21.7% | 472,532 | 0.0% | 0.47% | -16.7% |
| Q4 2018 | $9,512,000 | -19.0% | 472,532 | 0.0% | 0.57% | +0.9% |
| Q3 2018 | $11,742,000 | -9.5% | 472,532 | 0.0% | 0.56% | -15.0% |
| Q2 2018 | $12,971,000 | +31.9% | 472,532 | +48.0% | 0.66% | +6.9% |
| Q1 2018 | $9,835,000 | – | 319,313 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |